PHARMARON

3759
28.1400.14% ( +0.040 )
Delay Closed: Nov 16, 16:08:11

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: PHARMARON(03759) the Revenue is 5.157 B (+29.45%), Beat estimate;the EBIT is 718.05 M (+25.98%), Miss estimate;the EPS is 0.317 (--%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
5.16B29.45%
5.10B27.94%
+0.06B1.51%
EBITMiss expectations
0.72B25.98%
0.78B36.33%
-0.06B10.35%
EPSMiss expectations
0.3171--
0.3627--
-0.0456--%

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 26, 2027
Estimate Revenue19.65 B
Estimate EBIT--
Estimate EPS1.2386

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly